Paul R Edick insider trades
Open-market stock purchases and sales by Paul R Edick, Unknown at Vistagen Therapeutics, Inc, from SEC Form 4 filings since Nov 10, 2011.
Track record: 83% of 6 scored buys are up 5% or more since purchase, averaging +120%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 27, 2025 | VTGN Vistagen Therapeutics, Inc | Bought (not open market) | $137K |
Companies traded
- VTGN Vistagen Therapeutics, Inc: other filings, last Oct 27, 2025
- XERS Xeris Biopharma Holdings, Inc: 9 buys, last Jan 31, 2024
- MIST Milestone Pharmaceuticals Inc: other filings, last Jun 5, 2020
- ITRM Iterum Therapeutics plc: 1 buy, last May 24, 2019
- PDLI PDL Biopharma, Inc: other filings, last Jun 8, 2018
- SCMP Sucampo Pharmaceuticals, Inc: other filings, last Feb 13, 2018
- NEOS Neos Therapeutics, Inc: other filings, last Jul 3, 2017
- (NLNK) Newlink Genetics Corp: other filings, last May 12, 2017
- DRTX Durata Therapeutics, Inc: 4 buys, last Nov 17, 2014
- NLNK Newlink Genetics Corp: other filings, last Nov 2, 2012